[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@GonzaSanchezL Gonza
Gonza posts on X about $lly, novo, del, eps the most. They currently have XXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.
Engagements: XX #
- X Week XXX +40%
- X Year XXXXX -XX%
Mentions: X #
Followers: XXXXX #
- X Week XXXXX +0.29%
- X Month XXXXX -XXXX%
- X Months XXXXX +406%
- X Year XXXXX +165%
CreatorRank: undefined #
Social Influence #
Social category influence stocks finance
Social topic influence $lly #144, novo, del, eps, las
Top accounts mentioned or mentioned by @121 @fedekeller @jotatraderok @qualitystocksa @analyzingai
Top assets mentioned Eli Lilly and Company (LLY)
Top Social Posts #
Top posts by engagements in the last XX hours
"$LLY ya controla cerca del XX% del mercado global y sigue ampliando su liderazgo frente a Novo Nordisk. Q3 Earnings Call: "Lilly medicines account for nearly X out of XX prescriptions within this large and growing class""
X Link @GonzaSanchezL 2025-10-31T17:53Z 1043 followers, XXX engagements
"Increble los nmeros que presento $LLY en el Q3. -Revenue XXXX B (+54% interanual) -EPS XXXX vs 6.60E -Margen bruto XXXX% (+140bps y/y) -Monujaro (diabetes) 6.5B (+109 interanual) -Zepbound (perdida peso) 3.59B (+185% interanual) -Verzenio (cancer) 1.4B (+7% interanual)"
X Link @GonzaSanchezL 2025-10-30T13:16Z 1043 followers, XXX engagements
"En ultimo trimestre la empresa presento ventas por 800M y ebitda por 75M (margen del 9.4%). Si tomamos las ltimos XX meses las ventas ascienden a 3B y el ebitda a 300M"
X Link @GonzaSanchezL 2025-10-31T19:00Z 1043 followers, XX engagements